Mobile apps: Proposed FDA rule will disrupt industry
InformationWeek, July 22, 2011
The Food and Drug Administration's recent guidance on how it might regulate mobile health applications used by physicians and consumers will affect only a small portion of the apps on the market, the agency said. However, the FDA's expanded regulation of device-related software will affect device manufacturers and the growing number of firms marketing health apps for smartphones and tablets. "The majority of the folks who I've been dealing with do fall within the scope of that guidance document," said Bradley Thompson, a New York attorney specializing in medical device regulation.
Most Viewed
Most Emailed
- Urologists 'Outraged' Over PSA Test Challenge
- New Facebook Page Gathers Stories of Medical Harm
- Luxury Hospital Facilities Put Patient Experience First
- Five Hospitals Share Three Secrets to Improve Knee Surgery Outcomes
- Heartland Health Joins Mayo Clinic Network
- Health Insurance Exchanges Put Defined Benefits to the Test
- Beleaguered Fairview Health CEO to Retire in July
- How Rivals Built an ACO
- Challenging Physicians to Help Improve the ED
- TN Health System Charts Its Own Course

